{"ticker": {"uuid": "39ae302d-aa7b-4e53-a239-a4fa304747fd", "symbol": "CAPLIPOINT", "name": "Caplin Point Laboratories Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Caplin Point Laboratories declares no encumbrance on shares in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQc2ZDTldtRlEtR0hqMDlObHBvUkJ6d0RneDR2cVQtZTRaRVctaDNGa1M0YVJtMFlIdUFpYVQzZlJTajQtb3o2dW1kcVhMaENMMkV6UTc1cERnMFFtRVJjdlpEeTdLWlRyU1k5NV9seC1WWmVfbUFkOUtBOXZ5Q2x2T0Zkenl2b1prS2pWamR2eVgyUnpfMER0LUNCR0tvUlBQYU56bU5CR01SYXlrNmM1OFhWckVKZTZEdWlNNGVaajZuUQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories - Concurrent Gainers: 11 stocks gain for 5 straight sessions, rally up to 20%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxQLWpTOTJvYlFXRkZ2TVJURF83UmxyYmVhTTBNWUk2aVdmNkMwTFlXUG1EVEMzTVh0cFZLUzd6d1ZzV0ZpeElQMWExTko3SUNDS3pTTFphVl9GckN3QUZlaWM5R0taZ29SUGVyTm5KeXZYc1FrdVNvNU9oTHp6QVQ2NjFyZlhPYXRadU1wQ0xNUVZqajhQcXdEY1JCeEdJcTRaSDlzQjB5UWp0TUFSU2Q1bUpSUVlKWUUyak1vOU5ldWkxdmJLOEwteEwtNnV5eEJWdGo4eS04MmxlRVNaM0lSall0QlBYTHNxZHlkcjljR3lJUzJadEFXOEpERmRmNFU?oc=5", "source_name": "The Economic Times", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories - Retail investors' picks: 11 high-margin stocks surge up to 40% in CY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxNQk5ySkNpNWk5TnVwNzBRd3hrZWo2MHVoZ1p4cEUyaDQwa21uaHpCNlJEdGZEbHJMZ2tVZkRaX1ZMZUFidTJ1WUNGLUtIVUhpcDdYRGF2dWhyMGxST0pzZjA1YS1VQ2RxbmxEZGlqLTRJZG1aY21FWEFrQkEtSDFZUl9fSDVYY2t1R0t3d3pVbmtNRFRmdWNaOHNYREt1TGdETHFXaE96dXhyUmRFNGJBMmtJQXBvVkVBZFFoUlBUSExLY0lLMTZyMWVCVDkwUjYxTjJwXzFFcjV1d1A4VWdRem8zcjZycnVfandMeGoxS1p2QU1DY1dfbA?oc=5", "source_name": "The Economic Times", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Looks Like A Good Stock, And It's Going Ex-Dividend Soon", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point shares surge over 9% after Q4 results \u2014 Profit up 19%; dividend declared", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Reports FY26 PAT of \u20b9650 Crores, Up 20.1% YoY; Declares \u20b94 Interim Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxNZnFCTHNDZ19WeDRJNlBxVEI5Tnh1cXBYaW00TEhoOEN3enNGS2RyVGszSzg2ak56WVkyc2VQTDFPbTFZSjhuZ2VPellmRUl0N0JWb0hoUmVSbDJLR2NKNi10M2pNa2pjQWdYZ0JfdmNPQWlaTTZBQVhNTEFHVFhlNHBsQ0RqRENRQlgtNzR5LXRSSmFYN0h5VWttNlNpQm5HN3ZCNGw5NTY3dDZIbVFkZmpqX2IwVkpMNnN2WVJJT01DSmFwblJLU1JtNWNWWm5rTGNoQWh6djhFdk42ZXdJZEFsVHpueW9PUDN0Y0dOblJiRW8xbzRQRw?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Submits Q4FY26 SEBI Compliance Certificate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQTmRJbC1nM043M1BZbFdKSGppS2JWZjZycnhKSzQ1Y0Yxa2tUNWhuRmlUQ3RlT2JEWVJXNFpMQ3BQTTZ2aGlSY1BjLXp1VFA4N0xXcXBtLTl3eUVDODk1SC1JM1BCQ1hzTnNGLThYY1NyaGZxakVxa3Q1djdITm40WVdsSUtOTFVlTmlKYlN3RUdPSlItSmdDWmtJNmJoLUY4aER6Vjg0bDlqNl9mdEVOdEhZVGZ1S3NNc1I5NFR3UHE3a1E?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Receives USFDA Approval for Potassium Phosphates Injection", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOVFhFalAzV200bnpnY0d0a1NvSndDdVNlYlRzdTQyWDg3ZG04WDdnMjVDNi1ZaUktTzFwaklGMTZYYWFZVGl0cnpIOUlWZ3JzejN1SVZfQXkyM0UxOVhrTVBtdzdBbDdLSVlzUENoZkw1ZEZTOWRqaGxNOXhURDg3SUZ0b0xkcWVhN3B5VFg0ZjdJLWhsYVpMcm01Q0U2bTR2RC1pcG1rMWNsWm9rNHl0Y1JNS1A3SUJwbE5DcEQ1T3lBODdHcEdCNUMzT3FQVW9hR3ZZNTV3OVA?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Share Price Not Quite Adding Up", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Discloses Detailed Voting Results for Director Appointments", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNRUNOUTNla2RJZ1FuTy11SU9qT3M2djFYZndROFJNRHRGX05xelN5NVZ4RG40Sm9JekdiUXZLSWlycnd6bkJ2eVFVWkpJTHZGOHdWOUNkdWZoVktsbURZeVFibmdJNkNGd0tpLWZ1SWxkV3ZlVE12TEswa2NmNGNYdHF4N1YyUDNnZXpOOFlZcXhVLU52VTBwdzFkbTZoZ1JsSk1uRFZnOG5YYURHRjN4dm95OHVKMGx0d1I5QlBfNW9BVGFQZWlhZURIZ01jeHdrUzVjT2hfM3JwQjUwel9HXzlCVDRsM2Z0VWVraA?oc=5", "source_name": "scanx.trade", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Schedules Q3FY26 Earnings Conference Call for February 05, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPeGtReW1tZkhsQ0pZYncyand4OTJXYmFJUXlWSkpQSTdPM25vWDhVell4c21fR3EwR05NeWdfWVItblhkWHkzLXEtRVBQSXM3TXNQRVNzYjJfNzhhZEd3RVl1Z3RJY1RzR1FucV9BQmNERXotYVJEODQwUkxYSEFIOXBSVWJ3MzJITWhqbzJ6Nk85RkxDZTlqa3kxeklTYzF5VTJHdmhVNFR3b1BKNEpLdTdORWlJV3hLWU1sRmJOZmxFalQ2RXRaSU5JLTVfZEJJUDJGZ0lhOHA5WGZL?oc=5", "source_name": "scanx.trade", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxOZmVIa1cxOEYxWm9MREF2SW1NdmVzWkNRd0g1dF9VMXpydHEtUnNCdDNYb0QxZEJ1U3lVem9Ral9TYVpTU1pULTBUb3dfX082WjlrWUJTTDctb1JXRWg2VkMzZHFwTWJwbllJbGs0cnRJRWZ4NWdremgxT1F0ME1uQ2JxZGxSWmpCUzc3cUNvbWltMXNiMmpZeWM3YWVqUnZSdzZwcUFHT0o0OGY2ZmNYUldzR2FGQWE0NUVlY3U0UUlXQ0I2WXBQZDZoek5jQVZELU1DWVd1Y2JSX2ZGZGNmWkJxSkVyOXhaeU5KbHNEQXkwcE9pZGdWbFE0Sjg2d9IBgwJBVV95cUxNU01CMGZWMXMxVjBOMmRwVU84QkZfU2NXa0JlSzNMVzk4eElJVXFxRkpUNDdQZzVqSTBXSmxaZmRlcW5qYjN3VnV2Qms1NFVWYzJrbEJ2R01vZ0RIbWhycW0tSEJVY25QUUNXdlg1WWg2QS1BdU05OTYzaWVSUDJmWUp6SURYYWRES1NNNmFVcUlSNU9BRG5rNXhPSDgxdFowSUNZTTJEazREWXotaTBBX29WSWpFR053R2lZYzZTUUxNUDBnM1BZTXFwa3FqQkZsdmZJY2hpQjV0bHdzS1haN0NUX1dtakdPUDhZTTdVZTNSSzZ2SGRZMEJCZVRCUmdKZnA4?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Ltd. Share Price Live Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOMDZlTjFqMG01aWZfc1ZOTlRGLXhDdlJha3hxM3VsWGpORTd6djhmVVJjdF9WaGtJd0RsU0YwWlB1eENOUTJ4VmNpeEVGMTYwam1yYWlxVGJWeXNobmtuQXZfR3N4RmJxeG1fbVE4aXdBeEhtVjVLaFMwSTNEZXdVTHJES2R1SFN0WnZvV1hR?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T08:00:24+00:00", "published_display": "03 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories' (NSE:CAPLIPOINT) five-year earnings growth trails the strong shareholder returns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-26T08:00:00+00:00", "published_display": "26 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point bets big on US, complex injectables to drive next growth phase: COO", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Do Caplin Point Laboratories' (NSE:CAPLIPOINT) Earnings Warrant Your Attention?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-05T08:00:00+00:00", "published_display": "05 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) top holders are insiders and they are likely disappointed by the recent 3.4% drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxOalJkNkxkNXNTSU9zUmpxeHhudGdmazIzckEwdWFLQW1ua0JfaWpEZno4UHFLNmpPdGdlSERJNENrQTVkSDhTUDF6Q1VpSVhyMktzQ1dMR2pDSzhmbVh6TWlqS1pzVHprc3lrN0FWWTZEMGZ3RkJfYjhPRG90WDRxWUVtUU5sQ1NjLW1Kejh4SzRoRk9jZnVKSl9fdVhDX3doTG1lVEVSRFZId09xbzdfaDdWdUxkWUktakxscTVZc1ZYZjdQMUF4STVJUHE4UDRiY0hFYUF3QWJGTjR4QmlCRlVYRUo2Q0swSUx3d3Q3dzFEMFEwUmFGczRFVi03UdIBgwJBVV95cUxPaXUwYkc4emcyTUttazlFb0t5SV93MEo4R1FrV2VQSUM3bEdPcFE1MVFwVXprakhGbExTM3lPWHFXMkVHeXRJZkQyTjdVX1pIN3ZQYjlYT3hFOHlsNDd3WEd1M0RaOEdzUXZxRHR3WFpjeGw2QnNLazBsdmxEc1RkZTlhV3Q4WkJWU250dTk1aUVKQ0VBSlljYzEtYnR5ZlE1TlZrb3FjaEpMWXBMQ2xfYjZ2cW9fQlNDa19URkRnT2g5c1E0a0wzNUhsVnU4bXJIWG9VTzFia2tpN3lOV1N2SnNuTTR5VnBpQUFqS1ZQbmdHRzNnbURmeE9iZmRhU3hqeVc4?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-18T07:00:00+00:00", "published_display": "18 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Q1 Profit Up 20.7%; \u20b96 Dividend for FY25", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNTldVZDRsVHkxSnRmRWQydDBBQWdOQTRmSDNKZFBGeTB3cGxSWlFGQWhUMDVrdW4xWGJiQ0lwX09DQnZVRms5Mjd0UXdmMmJOc0FCNUpTWVR4cHVMcVVOcElIUF9hZDNqdEpfVzZ5RVlMV2t1QmhUVDlHWE1vVVhJNThR?oc=5", "source_name": "HDFC Sky", "published_at": "2025-08-07T07:00:00+00:00", "published_display": "07 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Lab Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE9rcFlIV1ZwVlRZWVJfbzRzMXBfaW5xN3V5RFo3dU9VeXpQaDFhclVFNkJDcFZyRHJOOEY3bUh6c3JldFBnZllXZWRnOF85enMwQ3VRSmJLeWlEX2VXSU1rUHlIV2g4ZUFhcUxj?oc=5", "source_name": "Upstox", "published_at": "2024-08-14T10:28:23+00:00", "published_display": "14 Aug 2024 10:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Ltd. Share Price Today | Caplin Point Lab Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOX3p3S1pXV1JFUHV4RVhlbW12THBKZG9wc1A0dWVIS0k5QVhpdUViblppdHMzMXFqUGhYakJmOWtKOFFJMjNmREtQb19OVl9WMmJFeHgyLUNDLTIzV2JaVnZldEhtUDVOTVkwVEY3Yms3Y09HRnItYS00N3BWREJ1bUN2ZXFRZw?oc=5", "source_name": "Value Research", "published_at": "2022-03-24T23:34:10+00:00", "published_display": "24 Mar 2022 23:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CAPLIN POINT LABORATORIES LIMITED", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQRmN4dmFjNDJzY05MMFdZaXZzSHA1eDdVVFdXRGRBYnJ3anVhdTU3VFZnTnRvMDRmam1JWkJGQW5aY2ZlcGxxWGNFTWlIYlFvbzBaRi1FdFkyQjlQQTFWRlozQzU4a0NUSno2Qmt0U3pGSXJVY0g0c2hxb1BtYjU1ZlVPaXdKWllmUVZWNHJ3ak85Zw?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-23T05:19:34+00:00", "published_display": "23 Aug 2020 05:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5YV2JvelZLTnNYY1g4U3ptRlRFNXE3RlBVajQxRGJtem9LTnpDQXdvU0RzY21zZHU5SWZQOUhaUFdMLWVwSW1aeGNCZnREMmk3R3NJel9PTmpDaGlWOUFRMGRSc1UyWTVXZG5Jb3JrQQ?oc=5", "source_name": "TradingView", "published_at": "2018-02-01T16:22:52+00:00", "published_display": "01 Feb 2018 16:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Caplin Point Laboratories declares no encumbrance on shares in FY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQc2ZDTldtRlEtR0hqMDlObHBvUkJ6d0RneDR2cVQtZTRaRVctaDNGa1M0YVJtMFlIdUFpYVQzZlJTajQtb3o2dW1kcVhMaENMMkV6UTc1cERnMFFtRVJjdlpEeTdLWlRyU1k5NV9seC1WWmVfbUFkOUtBOXZ5Q2x2T0Zkenl2b1prS2pWamR2eVgyUnpfMER0LUNCR0tvUlBQYU56bU5CR01SYXlrNmM1OFhWckVKZTZEdWlNNGVaajZuUQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories - Concurrent Gainers: 11 stocks gain for 5 straight sessions, rally up to 20%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_wFBVV95cUxQLWpTOTJvYlFXRkZ2TVJURF83UmxyYmVhTTBNWUk2aVdmNkMwTFlXUG1EVEMzTVh0cFZLUzd6d1ZzV0ZpeElQMWExTko3SUNDS3pTTFphVl9GckN3QUZlaWM5R0taZ29SUGVyTm5KeXZYc1FrdVNvNU9oTHp6QVQ2NjFyZlhPYXRadU1wQ0xNUVZqajhQcXdEY1JCeEdJcTRaSDlzQjB5UWp0TUFSU2Q1bUpSUVlKWUUyak1vOU5ldWkxdmJLOEwteEwtNnV5eEJWdGo4eS04MmxlRVNaM0lSall0QlBYTHNxZHlkcjljR3lJUzJadEFXOEpERmRmNFU?oc=5", "source_name": "The Economic Times", "published_at": "2026-06-13T07:00:00+00:00", "published_display": "13 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories - Retail investors' picks: 11 high-margin stocks surge up to 40% in CY26", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxNQk5ySkNpNWk5TnVwNzBRd3hrZWo2MHVoZ1p4cEUyaDQwa21uaHpCNlJEdGZEbHJMZ2tVZkRaX1ZMZUFidTJ1WUNGLUtIVUhpcDdYRGF2dWhyMGxST0pzZjA1YS1VQ2RxbmxEZGlqLTRJZG1aY21FWEFrQkEtSDFZUl9fSDVYY2t1R0t3d3pVbmtNRFRmdWNaOHNYREt1TGdETHFXaE96dXhyUmRFNGJBMmtJQXBvVkVBZFFoUlBUSExLY0lLMTZyMWVCVDkwUjYxTjJwXzFFcjV1d1A4VWdRem8zcjZycnVfandMeGoxS1p2QU1DY1dfbA?oc=5", "source_name": "The Economic Times", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Looks Like A Good Stock, And It's Going Ex-Dividend Soon", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point shares surge over 9% after Q4 results \u2014 Profit up 19%; dividend declared", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Reports FY26 PAT of \u20b9650 Crores, Up 20.1% YoY; Declares \u20b94 Interim Dividend", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxNZnFCTHNDZ19WeDRJNlBxVEI5Tnh1cXBYaW00TEhoOEN3enNGS2RyVGszSzg2ak56WVkyc2VQTDFPbTFZSjhuZ2VPellmRUl0N0JWb0hoUmVSbDJLR2NKNi10M2pNa2pjQWdYZ0JfdmNPQWlaTTZBQVhNTEFHVFhlNHBsQ0RqRENRQlgtNzR5LXRSSmFYN0h5VWttNlNpQm5HN3ZCNGw5NTY3dDZIbVFkZmpqX2IwVkpMNnN2WVJJT01DSmFwblJLU1JtNWNWWm5rTGNoQWh6djhFdk42ZXdJZEFsVHpueW9PUDN0Y0dOblJiRW8xbzRQRw?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Submits Q4FY26 SEBI Compliance Certificate", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQTmRJbC1nM043M1BZbFdKSGppS2JWZjZycnhKSzQ1Y0Yxa2tUNWhuRmlUQ3RlT2JEWVJXNFpMQ3BQTTZ2aGlSY1BjLXp1VFA4N0xXcXBtLTl3eUVDODk1SC1JM1BCQ1hzTnNGLThYY1NyaGZxakVxa3Q1djdITm40WVdsSUtOTFVlTmlKYlN3RUdPSlItSmdDWmtJNmJoLUY4aER6Vjg0bDlqNl9mdEVOdEhZVGZ1S3NNc1I5NFR3UHE3a1E?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Receives USFDA Approval for Potassium Phosphates Injection", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxOVFhFalAzV200bnpnY0d0a1NvSndDdVNlYlRzdTQyWDg3ZG04WDdnMjVDNi1ZaUktTzFwaklGMTZYYWFZVGl0cnpIOUlWZ3JzejN1SVZfQXkyM0UxOVhrTVBtdzdBbDdLSVlzUENoZkw1ZEZTOWRqaGxNOXhURDg3SUZ0b0xkcWVhN3B5VFg0ZjdJLWhsYVpMcm01Q0U2bTR2RC1pcG1rMWNsWm9rNHl0Y1JNS1A3SUJwbE5DcEQ1T3lBODdHcEdCNUMzT3FQVW9hR3ZZNTV3OVA?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Share Price Not Quite Adding Up", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Discloses Detailed Voting Results for Director Appointments", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNRUNOUTNla2RJZ1FuTy11SU9qT3M2djFYZndROFJNRHRGX05xelN5NVZ4RG40Sm9JekdiUXZLSWlycnd6bkJ2eVFVWkpJTHZGOHdWOUNkdWZoVktsbURZeVFibmdJNkNGd0tpLWZ1SWxkV3ZlVE12TEswa2NmNGNYdHF4N1YyUDNnZXpOOFlZcXhVLU52VTBwdzFkbTZoZ1JsSk1uRFZnOG5YYURHRjN4dm95OHVKMGx0d1I5QlBfNW9BVGFQZWlhZURIZ01jeHdrUzVjT2hfM3JwQjUwel9HXzlCVDRsM2Z0VWVraA?oc=5", "source_name": "scanx.trade", "published_at": "2026-02-03T08:00:00+00:00", "published_display": "03 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Schedules Q3FY26 Earnings Conference Call for February 05, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPeGtReW1tZkhsQ0pZYncyand4OTJXYmFJUXlWSkpQSTdPM25vWDhVell4c21fR3EwR05NeWdfWVItblhkWHkzLXEtRVBQSXM3TXNQRVNzYjJfNzhhZEd3RVl1Z3RJY1RzR1FucV9BQmNERXotYVJEODQwUkxYSEFIOXBSVWJ3MzJITWhqbzJ6Nk85RkxDZTlqa3kxeklTYzF5VTJHdmhVNFR3b1BKNEpLdTdORWlJV3hLWU1sRmJOZmxFalQ2RXRaSU5JLTVfZEJJUDJGZ0lhOHA5WGZL?oc=5", "source_name": "scanx.trade", "published_at": "2026-01-29T08:00:00+00:00", "published_display": "29 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Ltd. Share Price Live Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOMDZlTjFqMG01aWZfc1ZOTlRGLXhDdlJha3hxM3VsWGpORTd6djhmVVJjdF9WaGtJd0RsU0YwWlB1eENOUTJ4VmNpeEVGMTYwam1yYWlxVGJWeXNobmtuQXZfR3N4RmJxeG1fbVE4aXdBeEhtVjVLaFMwSTNEZXdVTHJES2R1SFN0WnZvV1hR?oc=5", "source_name": "CNBC TV18", "published_at": "2026-01-03T08:00:24+00:00", "published_display": "03 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories' (NSE:CAPLIPOINT) five-year earnings growth trails the strong shareholder returns", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-26T08:00:00+00:00", "published_display": "26 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point bets big on US, complex injectables to drive next growth phase: COO", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2025-12-17T08:00:00+00:00", "published_display": "17 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Do Caplin Point Laboratories' (NSE:CAPLIPOINT) Earnings Warrant Your Attention?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-05T08:00:00+00:00", "published_display": "05 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) top holders are insiders and they are likely disappointed by the recent 3.4% drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-18T07:00:00+00:00", "published_display": "18 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-16T07:00:00+00:00", "published_display": "16 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Q1 Profit Up 20.7%; \u20b96 Dividend for FY25", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNTldVZDRsVHkxSnRmRWQydDBBQWdOQTRmSDNKZFBGeTB3cGxSWlFGQWhUMDVrdW4xWGJiQ0lwX09DQnZVRms5Mjd0UXdmMmJOc0FCNUpTWVR4cHVMcVVOcElIUF9hZDNqdEpfVzZ5RVlMV2t1QmhUVDlHWE1vVVhJNThR?oc=5", "source_name": "HDFC Sky", "published_at": "2025-08-07T07:00:00+00:00", "published_display": "07 Aug 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Lab Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE9rcFlIV1ZwVlRZWVJfbzRzMXBfaW5xN3V5RFo3dU9VeXpQaDFhclVFNkJDcFZyRHJOOEY3bUh6c3JldFBnZllXZWRnOF85enMwQ3VRSmJLeWlEX2VXSU1rUHlIV2g4ZUFhcUxj?oc=5", "source_name": "Upstox", "published_at": "2024-08-14T10:28:23+00:00", "published_display": "14 Aug 2024 10:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Caplin Point Laboratories Ltd. Share Price Today | Caplin Point Lab Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOX3p3S1pXV1JFUHV4RVhlbW12THBKZG9wc1A0dWVIS0k5QVhpdUViblppdHMzMXFqUGhYakJmOWtKOFFJMjNmREtQb19OVl9WMmJFeHgyLUNDLTIzV2JaVnZldEhtUDVOTVkwVEY3Yms3Y09HRnItYS00N3BWREJ1bUN2ZXFRZw?oc=5", "source_name": "Value Research", "published_at": "2022-03-24T23:34:10+00:00", "published_display": "24 Mar 2022 23:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CAPLIN POINT LABORATORIES LIMITED", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQRmN4dmFjNDJzY05MMFdZaXZzSHA1eDdVVFdXRGRBYnJ3anVhdTU3VFZnTnRvMDRmam1JWkJGQW5aY2ZlcGxxWGNFTWlIYlFvbzBaRi1FdFkyQjlQQTFWRlozQzU4a0NUSno2Qmt0U3pGSXJVY0g0c2hxb1BtYjU1ZlVPaXdKWllmUVZWNHJ3ak85Zw?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-23T05:19:34+00:00", "published_display": "23 Aug 2020 05:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Analysis of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE5YV2JvelZLTnNYY1g4U3ptRlRFNXE3RlBVajQxRGJtem9LTnpDQXdvU0RzY21zZHU5SWZQOUhaUFdMLWVwSW1aeGNCZnREMmk3R3NJel9PTmpDaGlWOUFRMGRSc1UyWTVXZG5Jb3JrQQ?oc=5", "source_name": "TradingView", "published_at": "2018-02-01T16:22:52+00:00", "published_display": "01 Feb 2018 16:22", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 23, "sentiment_summary": {"positive": 7, "negative": 0, "neutral": 16, "score": 57, "total": 23, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 9.65, "count": 15}, {"event": "earnings", "label": "Earnings", "weight": 3.65, "count": 6}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 2583.6, "latest_week": "2026-07-10", "one_week_move": 1.8, "four_week_move": 7.3, "twelve_week_move": 46.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.629124, "market_dynamics_buy_signal": false, "relative_strength": 34.324847, "fair_value_gap": 48.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 57.8168, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.8% over one week, +7.3% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 67, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 7}, {"label": "scanx.trade", "count": 6}, {"label": "The Economic Times", "count": 3}, {"label": "CNBC TV18", "count": 2}, {"label": "HDFC Sky", "count": 1}, {"label": "Upstox", "count": 1}, {"label": "Value Research", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 23}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}, {"label": "Earnings", "count": 6}, {"label": "Capital return", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "23", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+1.8% over one week, +7.3% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Caplin Point Laboratories declares no encumbrance on shares in FY26"}], "updated_at": "2026-07-18T03:12:17.268783+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}